Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 27, 2019 - Issue 5
Submit an article Journal homepage
219
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy and Safety of Mycophenolate Mofetil in the Treatment of Recalcitrant Intermediate Uveitis

Sowkath AliUvea Department, Sankara Nethralaya, Chennai, India
, MS,
Ranju Kharel SitaulaDepartment of Ophthalmology, Maharajgunj Medical Campus, B. P. Koirala Lions Centre for Ophthalmic Studies, Tribhuvan University, Institute of Medicine, Maharajgunj, Kathmandu, Nepal
, MD, FAICO &
Jyotirmay BiswasMedical and Vision Research Foundations, Sankara Nethralaya, Chennai, IndiaCorrespondence[email protected]
, MS, FMRF, FNAMS, FIC Path, FAICO
Pages 851-857 | Received 21 Apr 2017, Accepted 14 Mar 2018, Published online: 13 Apr 2018

References

  • Chanaud MP, Vistica BP, Eugin E, et al. Inhibition of experimental autoimmune uveoretinitis by Mycophenolate Mofetilan inhibitor of purine metabolism. Exp Eye Res. 1995;61:429–434.
  • Nogueras F, Espinosa MD, Mansilla A, Torres JT, Cabrera MA, Martin-Vivaldi R. Mycophenolate Mofetil-induced neutropenia in liver transplantation. Transplant Proc. 2005;37:1509–1511.
  • Spatz S, Rudnicka A, McDonald CJ. Mycophenolic acid in psoriasis. Br J Dermatol. 1978;98:429–435.
  • Kilmartin DJ, Forrester JV, Dick AD. Rescue therapy with Mycophenolate Mofetil in refractory uveitis. Lancet. 1998;352:35–36.
  • Choudhary A, Harding SP, Bucknall RC, Pearce IA. Mycophenolate Mofetil as an immunosuppressive agent in refractory inflammatory eye disease. J Ocul Pharmacol Ther. 2006;22:168–175.
  • Larkin G, Lightman S. Mycophenolate Mofetil a useful immunosuppressive in inflammatory eye disease. Ophthalmology. 1999;10:6370–6374.
  • Siepmann K, Huber M, Stübiger N, Deuter C, Zierhut M. Mycophenolate Mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis: A retrospective analysis of 106 patients. Graefe’s Arch Clin Exp Ophthalmol. 2006;244:788–794.
  • Rathinam SR, Babu M, Thundikandy R, et al. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for non-infectious uveitis. Ophthalmology. 2014;121(10):1863–1870.
  • Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516.
  • Esterberg E, Acharya NR. Corticosteroid-sparing therapy: practice patterns among uveitis specialists. J Ophthal Inflamm Infect. 2012;2:21–28.
  • Galor A, Jabs DA, Leder HA, et al. Comparison of antimetabolite drugs as corticosteroid – sparing therapy for noninfectious ocular inflammation. Ophthalmology. 2008;115:1826–1832.
  • Thorne JE, Jabs DA, Qazi FA, et al. Mycophenolate Mofetil therapy for inflammatory eye disease. Ophthalmology. 2005;112:1472–1477.
  • Daniel E, Thorne JE, Newcomb CW, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010;149(3):423–432.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.